Abhinav Sidana to Male
This is a "connection" page, showing publications Abhinav Sidana has written about Male.
Connection Strength
1.106
-
Prostate ablation for the management of localized prostate cancer. Urol Oncol. 2025 Mar; 43(3):194.e9-194.e17.
Score: 0.048
-
Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer. Urol Oncol. 2024 05; 42(5):158.e1-158.e10.
Score: 0.045
-
Real-Time and Delayed Imaging of Tissue and Effects of Prostate Tissue Ablation. Curr Urol Rep. 2023 Oct; 24(10):477-489.
Score: 0.043
-
Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients? Aging Male. 2022 Dec; 25(1):23-28.
Score: 0.042
-
How does a prebiopsy mri approach for prostate cancer diagnosis affect prostatectomy upgrade rates? Urol Oncol. 2021 11; 39(11):784.e11-784.e16.
Score: 0.037
-
Is a targeted biopsy-only approach for prostate cancer diagnosis ready for the prime time? Nat Rev Urol. 2021 02; 18(2):75-76.
Score: 0.037
-
Multiparametric MRI-ultrasound fusion prostate biopsy in patients without prior diagnosis of prostate cancer: beyond centers of excellence. Aging Male. 2020 Dec; 23(5):1570-1575.
Score: 0.037
-
A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies. J Endourol. 2020 10; 34(10):1095-1098.
Score: 0.036
-
Equal access to health care reduces racial disparities in prostate cancer outcomes. Cancer. 2020 09 15; 126(18):4256-4257.
Score: 0.035
-
Multidisciplinary clinics: A possible means to help to eliminate racial disparities in prostate cancer. Cancer. 2020 06 15; 126(12):2938-2939.
Score: 0.034
-
Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer. Prostate Cancer Prostatic Dis. 2020 12; 23(4):567-572.
Score: 0.034
-
Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies. Int Urol Nephrol. 2019 Jul; 51(7):1101-1106.
Score: 0.032
-
Partial gland therapy for prostate cancer. Cancer. 2019 03 01; 125(5):818-819.
Score: 0.032
-
False-Positive Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions: A Discussion of Possible Mechanisms. AJR Am J Roentgenol. 2018 11; 211(5):W277.
Score: 0.031
-
Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol. 2018 Jul; 53(3):227-233.
Score: 0.030
-
Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI. AJR Am J Roentgenol. 2018 06; 210(6):W268.
Score: 0.030
-
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
Score: 0.030
-
Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol. 2018 Jul; 53(3):200-205.
Score: 0.030
-
The Sunshine Act and oncology: Lessons learned from urology. Semin Oncol. 2017 08; 44(4):265-266.
Score: 0.029
-
Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol. 2017 03; 35(3):114.e9-114.e14.
Score: 0.027
-
Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy. Int Urol Nephrol. 2016 Jul; 48(7):1047-1053.
Score: 0.026
-
Utility of smartphone camera in patient management in urology. Can J Urol. 2014 Oct; 21(5):7449-53.
Score: 0.024
-
Effect of renal embolization and cryoablation on regulatory T cells in advanced renal cell carcinoma. Cryobiology. 2013 Apr; 66(2):95.
Score: 0.021
-
Determinants of outcomes after resection of renal cell carcinoma with venous involvement. Int Urol Nephrol. 2012 Dec; 44(6):1671-9.
Score: 0.021
-
Mechanism of growth inhibition of prostate cancer xenografts by valproic acid. J Biomed Biotechnol. 2012; 2012:180363.
Score: 0.021
-
Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy. Urol Res. 2012 Dec; 40(6):805-6.
Score: 0.021
-
Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012 Jan; 72(1):58-64.
Score: 0.019
-
Does valproic acid induce neuroendocrine differentiation in prostate cancer? J Biomed Biotechnol. 2011; 2011:607480.
Score: 0.018
-
Complications of renal cryoablation: a single center experience. J Urol. 2010 Jul; 184(1):42-7.
Score: 0.017
-
Quality of life and autonomy preferences in stable asthmatics: a developing country scenario. Respirology. 2009 Jan; 14(1):83-9.
Score: 0.016
-
Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022 Mar-Apr; 48(2):263-274.
Score: 0.010
-
MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. Diagn Interv Radiol. 2021 May; 27(3):394-400.
Score: 0.009
-
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urol Oncol. 2021 11; 39(11):781.e17-781.e24.
Score: 0.009
-
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. Minerva Urol Nephrol. 2022 10; 74(5):581-589.
Score: 0.009
-
Tobacco smoking induces metabolic reprogramming of renal cell carcinoma. J Clin Invest. 2021 01 04; 131(1).
Score: 0.009
-
Imaging for prostate cancer: reimbursements. Abdom Radiol (NY). 2020 12; 45(12):4114-4116.
Score: 0.009
-
Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World J Urol. 2021 Mar; 39(3):677-686.
Score: 0.009
-
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. Eur Urol. 2020 09; 78(3):371-378.
Score: 0.009
-
Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy. Int Urol Nephrol. 2020 Apr; 52(4):633-638.
Score: 0.008
-
Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy. Int Urol Nephrol. 2019 Aug; 51(8):1349-1355.
Score: 0.008
-
Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer. Urol Oncol. 2019 03; 37(3):182.e1-182.e8.
Score: 0.008
-
Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer. J Magn Reson Imaging. 2018 11; 48(5):1326-1335.
Score: 0.008
-
Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? J Urol. 2018 04; 199(4):976-982.
Score: 0.007
-
Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. Int Urol Nephrol. 2018 Feb; 50(2):257-262.
Score: 0.007
-
Ruling out clinically significant prostate cancer with negative multi-parametric MRI. Int Urol Nephrol. 2018 Jan; 50(1):7-12.
Score: 0.007
-
Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer. Balkan Med J. 2017 09 29; 34(5):388-396.
Score: 0.007
-
MRI-targeted biopsy: is systematic biopsy obsolete? Can J Urol. 2017 Aug; 24(4):8876-8882.
Score: 0.007
-
Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional Outcomes. J Endourol. 2016 Nov; 30(11):1219-1226.
Score: 0.007
-
Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. Urol Oncol. 2017 01; 35(1):32.e1-32.e7.
Score: 0.007
-
Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy. J Urol. 2017 02; 197(2):327-334.
Score: 0.007
-
Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis. Urol Oncol. 2017 01; 35(1):30.e1-30.e8.
Score: 0.007
-
Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Int Urol Nephrol. 2016 Sep; 48(9):1445-52.
Score: 0.007
-
The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. Urol Oncol. 2016 06; 34(6):254.e15-21.
Score: 0.007
-
Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling. J Urol. 2016 07; 196(1):62-7.
Score: 0.006
-
Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol. 2012 Nov; 26(11):1413-9.
Score: 0.005
-
Large renal metastasis from rare pulmonary neoplasm. Urology. 2011 May; 77(5):1097-8.
Score: 0.004
-
Preoperative diagnosis of malignant mesothelioma of the tunica vaginalis using Doppler ultrasound. Urology. 2010 Feb; 75(2):251-2.
Score: 0.004